≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Toxic effect of alcohol

EFO MESH Endpoint Browser PheWeb

ST19_TOXIC_EFFECT_ALCOHOL

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — T51
  • Hospital discharge: ICD-9 — 980
  • Hospital discharge: ICD-8 — 980
  • Hospital discharge: excluded ICD-10 — T51.0
  • Hospital discharge: excluded ICD-9 — 9800
  • Cause of death: ICD-10 — T51
  • Cause of death: ICD-9 — 980
  • Cause of death: ICD-8 — 980
  • Cause of death: excluded ICD-10 — T51.0
  • Cause of death: excluded ICD-9 — 9800

2 out of 7 registries used, show all original rules.

817

4. Check minimum number of events

None

817

5. Include endpoints

None

817

6. Filter based on genotype QC (FinnGen only)

817

Control definitions (FinnGen only)

Control exclude
ST19_TOXIC_EFFEC_SUBST_CHIEF_NONME_SOURCE

Extra metadata

Level in the ICD hierarchy
3
Special
ALCOTOXIC
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
T51-T65
Name in latin
Effectus alcoholicus toxicus

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 10946 3014 7772
Only index persons 7769 2497 5272
Unadjusted period prevalence (%)
Whole population 0.18 0.09 0.22
Only index persons 0.17 0.09 0.20
Median age at first event (years)
Whole population 28.20 21.94 30.22
Only index persons 22.55 19.17 24.15

-FinnGen-

Key figures

All Female Male
Number of individuals 817 302 515
Unadjusted period prevalence (%) 0.18 0.10 0.23
Median age at first event (years) 25.36 20.34 28.31

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
755
Matched controls
7550
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
98000
ICD-8 Finland
Toxic effect of alcohol, Ethyl alcohol
+∞
323.0
396
*
T51.9
ICD-10 Finland
Toxic effect: Alcohol, unspecified
+∞
147.9
137
*
E8699
ICD-8 Finland
Accidental poisoning by other and unspecified solid and liquid substances
199.3
116.1
118
7
X45
ICD-10 Finland
Accidental poisoning by and exposure to alcohol
232.7
100.1
101
5
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
9.7
93.8
208
284
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
18.2
85.1
136
90
T36
ICD-10 Finland
Poisoning by systemic antibiotics
12.5
73.0
137
131
T51.0
ICD-10 Finland
Toxic effect: Ethanol
+∞
68.8
65
*
98099
ICD-8 Finland
Toxic effect of alcohol, Other
+∞
60.2
57
*
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
49.8
53.2
64
14
T51.1
ICD-10 Finland
Toxic effect: Methanol
+∞
52.7
50
*
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
18.8
52.0
81
48
T51.8
ICD-10 Finland
Toxic effect: Other alcohols
+∞
51.7
49
*
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
11.6
46.0
88
85
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
29.8
43.2
58
21
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
14.0
42.5
74
58
30320
ICD-8 Finland
Alcoholism, Alcoholic addiction
32.8
42.0
55
18
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
36.3
39.9
51
15
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
18.5
33.7
52
30
F10.20
ICD-10 Finland
Alcohol dependence currently independent
10.7
33.0
65
66
30310
ICD-8 Finland
Alcoholism, Habitual excessive drinking
29.1
32.8
44
16
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.9
32.5
148
442
N05AA02
ATC
levomepromazine; systemic
6.7
32.1
85
140
N07BB01
ATC
disulfiram; oral
5.5
31.9
99
200
F10.09
ICD-10 Finland
Alcohol intoxication UNS
9.5
31.6
66
75
N05BA01
ATC
diazepam; systemic, rectal
3.5
29.5
158
533
E9809
ICD-8 Finland
Poisoning by solid or liquid substances, undetermined whether accidentally or purposely inflicted, Other and unspecified solid and liquid substances
68.8
29.1
33
5
N05BA02
ATC
chlordiazepoxide; systemic
9.5
28.7
60
68
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
10.7
28.7
56
56
N05AH04
ATC
quetiapine; oral
3.0
27.5
180
704
F10.24
ICD-10 Finland
Alcohol depence active use
11.3
26.4
50
47
N05BA04
ATC
oxazepam; oral
2.7
26.0
219
999
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.1
25.1
105
287
N05CD07
ATC
temazepam; oral
3.5
25.1
127
409
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
17.1
24.7
39
24
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
11.6
24.7
46
42
F10.25
ICD-10 Finland
Alcohol dependence continuous use
8.6
24.6
54
67
N06AX11
ATC
mirtazapine; oral
2.4
24.2
277
1479
P15
ICPC
Chronic alcohol abuse
6.2
23.8
66
115
T51.2
ICD-10 Finland
Toxic effect: 2-Propanol
+∞
23.0
22
*
V03AA01
ATC
NA
10.8
22.9
44
43
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
11.7
22.2
41
37
N05CF01
ATC
zopiclone; oral
2.3
21.2
260
1417
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
11.7
20.7
38
34
N06AB04
ATC
citalopram; systemic
2.5
20.1
186
876
P16
ICPC
Acute alcohol abuse
7.7
19.7
46
63
N05AB01
ATC
dixyrazine; systemic
12.7
19.2
34
28
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
11.8
18.6
34
30
30399
ICD-8 Finland
Other and unspecified alcoholism
33.8
18.0
23
7
B18.2
ICD-10 Finland
Chronic viral hepatitis C
14.1
17.9
30
22
9809X
ICD-9 Finland
Toxic effect of alcohol, Unspecified alcohol
+∞
17.8
17
*
N03AG01
ATC
valproic acid; systemic, rectal
3.7
17.3
78
227
R40.2
ICD-10 Finland
Coma, unspecified
16.4
17.1
27
17
30180
ICD-8 Finland
Personality disorders, Immatura
17.9
17.0
26
15
S06.0
ICD-10 Finland
Concussion
3.0
17.0
102
368
N05BE01
ATC
buspirone; oral
6.3
16.6
44
73
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
9.3
16.6
34
38
E970A
ICD-9 Finland
Injury due to legal intervention by firearms
173.7
16.6
17
*
N05AF03
ATC
chlorprothixene; systemic
6.1
16.4
45
78
N06AB03
ATC
fluoxetine; oral
2.8
16.3
116
466
E9599
ICD-8 Finland
Late effect of self-inflicted injury
61.4
15.8
18
*
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
11.1
15.6
29
27
Y91.1
ICD-10 Finland
Moderate alcohol intoxication
163.2
15.5
16
*
N05AH03
ATC
olanzapine; systemic
3.5
15.4
74
227
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.2
15.1
82
276
9800A
ICD-9 Finland
Toxic effect of alcohol, Ethyl alcohol
57.9
14.8
17
*
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
8.0
14.7
33
43
N05AD01
ATC
haloperidol; systemic
5.7
14.7
42
77
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.8
14.7
63
176
Y91.2
ICD-10 Finland
Severe alcohol intoxication
+∞
14.6
14
*
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
+∞
14.6
14
*
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
36.8
14.5
18
5
K92.0
ICD-10 Finland
Haematemesis
5.9
14.4
40
71
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
14.3
219
1270
30188
ICD-8 Finland
Personality disorders, Alia definita
27.8
14.3
19
7
N05AH02
ATC
clozapine; systemic
6.5
14.0
36
58
E8599
ICD-8 Finland
Accidental poisoning by other and unspecified drugs and medicaments, Drugs, unspecified
24.3
13.8
19
8
AA1AD
NOMESCO Finland
CT of head and brain
2.1
13.7
177
956
F61.0
ICD-10 Finland
Mixed personality disorders
8.2
13.7
30
38
5353A
ICD-9 Finland
Gastritis and duodenitis, Alcoholic gastritis
+∞
13.6
13
*
F60.9
ICD-10 Finland
Personality disorder, unspecified
8.5
13.1
28
34
N06AX03
ATC
mianserin; oral
4.2
13.1
50
126
E850A
ICD-9 Finland
Accidental poisoning by analgesics, antipyretics, antirheumatics
50.9
12.9
15
*
85000
ICD-8 Finland
Concussion, Current or unspecified
5.4
12.7
38
74
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
7.2
12.7
30
43
30041
ICD-8 Finland
Neuroses, Depressiva
7.6
12.3
28
38
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.9
12.1
76
282
Z72.1
ICD-10 Finland
Alcohol use
7.4
12.1
28
39
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
11.9
110
509
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.9
11.8
38
81
C07AA05
ATC
propranolol; systemic
2.1
11.7
143
751
N05AX08
ATC
risperidone; systemic
3.0
11.7
68
240
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
8.3
11.6
25
31
F10.07
ICD-10 Finland
Pathological alcohol intoxication
66.0
11.6
13
*
96798
ICD-8 Finland
Other sleeping pills and sedatives
66.0
11.6
13
*
N06AA12
ATC
doxepin; systemic
3.5
11.5
54
163
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
11.4
122
602
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
15.3
11.3
18
12
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
11.2
129
659
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
11.4
11.1
20
18
N05AD03
ATC
melperone; systemic
8.7
11.1
23
27
N05AB03
ATC
perphenazine; systemic, rectal
4.0
11.1
44
116
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.9
10.9
66
238
N05CD02
ATC
nitrazepam; oral
8.4
10.9
23
28
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
4.6
10.9
37
84
30000
ICD-8 Finland
Neuroses, Anxiety neurosis
11.4
10.6
19
17
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.9
10.5
42
111
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
14.5
10.5
17
12
98020
ICD-8 Finland
Toxic effect of alcohol, Isopropyl alcohol
+∞
10.4
10
*
N04AA02
ATC
biperiden; systemic
5.6
10.4
29
53
2918A
ICD-9 Finland
Alcoholic psychoses, Other specified alcoholic psychosis
33.0
10.4
13
*
2910A
ICD-9 Finland
Alcoholic psychoses, Alcohol withdrawal delirium
33.0
10.4
13
*
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
9.3
10.1
20
22
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
10.2
10.1
19
19
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
10.0
147
827
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
40.6
10.0
12
*
N06AB06
ATC
sertraline; oral
2.3
9.9
94
438
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.8
9.9
41
113
97010
ICD-8 Finland
Adverse effect of psychotherapeutics, Tranquillisers
26.4
9.8
13
5
N06AX16
ATC
venlafaxine; oral
2.1
9.8
111
561
29120
ICD-8 Finland
Alcoholic psychosis, Other alcoholic hallucinosis
55.7
9.7
11
*
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
15.3
9.5
15
10
N06AB10
ATC
escitalopram; oral
1.9
9.5
152
881
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
9.5
170
1027
N05BA12
ATC
alprazolam; oral
2.4
9.4
84
380
Y91.0
ICD-10 Finland
Mild alcohol intoxication
101.2
9.4
10
*
F60.2
ICD-10 Finland
Dissocial personality disorder
17.8
9.4
14
8
A06AD11
ATC
lactulose; oral
2.1
9.4
107
544
30040
ICD-8 Finland
Neuroses, Neurotico-depressiva
12.5
9.4
16
13
E9609
ICD-8 Finland
Fight, brawl, rape
10.8
9.3
17
16
N06AB05
ATC
paroxetine; oral
2.9
9.2
57
209
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
13.9
9.2
15
11
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
6.0
9.1
24
41
P99
ICPC
Psychological disorders other
4.4
9.1
32
76
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
9.2
9.1
18
20
97940
ICD-8 Finland
Alcohol in combination with specified medicinal agents, With psychopharmacological agents
37.2
9.0
11
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.5
8.8
69
293
SPAT1265
SPAT
Breathalyser
6.7
8.7
21
32
P29
ICPC
Psychological sympt/compl other
2.8
8.7
55
207
E8859
ICD-8 Finland
Fall on same level from slipping, stumbling or tripping
3.1
8.6
45
149
N05AX12
ATC
aripiprazole; systemic
3.3
8.6
42
133
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
16.5
8.6
13
8
P01
ICPC
Feeling anxious/nervous/tense
2.4
8.5
75
337
N02AX02
ATC
tramadol; systemic, rectal
1.6
8.4
294
2149
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.4
8.4
29
68
N03AX09
ATC
lamotrigine; oral
3.1
8.4
44
147
79301
ICD-8 Finland
Observation, without need for further medical care, Observatio post tentationem suicidii
+∞
8.3
8
*
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
8.7
8.3
17
20
P18
ICPC
Medication abuse
14.7
8.2
13
9
N05AC02
ATC
thioridazine; oral
4.9
8.1
25
52
29100
ICD-8 Finland
Alcoholic psychosis, Delirium tremens
33.7
8.1
10
*
92000
ICD-8 Finland
Contusion of face, scalp and neck except eye(s), Current injury
9.1
8.1
16
18
F10.05
ICD-10 Finland
Alcohol-related acute intoxication with coma
22.3
8.0
11
5
30199
ICD-8 Finland
Personality disorders, Unspecified
22.3
8.0
11
5
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
5.5
7.9
22
41
F10.3
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state
10.9
7.8
14
13
V03AB30
ATC
NA
9.5
7.8
15
16
X84
ICD-10 Finland
Intentional self-harm by unspecified means
45.4
7.7
9
*
W19
ICD-10 Finland
Unspecified fall
2.3
7.7
73
341
N07BA03
ATC
varenicline; oral
2.8
7.7
49
185
N05BA06
ATC
lorazepam; systemic, sublingual
3.0
7.7
44
155
X78
ICD-10 Finland
Intentional self-harm by sharp object
12.0
7.6
13
11
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
12.0
7.6
13
11
S01.0
ICD-10 Finland
Open wound of scalp
2.4
7.6
62
270
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
6.3
7.6
19
31
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.9
7.6
44
157
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.7
7.4
31
87
WX730
NOMESCO Finland
Conventional respirator
4.6
7.4
24
53
K70.1
ICD-10 Finland
Alcoholic hepatitis
7.8
7.4
16
21
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
7.3
68
315
T51
ICD-10 Finland
Toxic effect of alcohol
+∞
7.3
7
*
3017A
ICD-9 Finland
Personality disorders, Antisocial personality disorder
+∞
7.3
7
*
98098
ICD-8 Finland
Toxic effect of alcohol, Other alcohols
+∞
7.3
7
*
30799
ICD-8 Finland
Transient situational disturbances
15.9
7.2
11
7
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.2
7.1
74
361
N03AF01
ATC
carbamazepine; oral, rectal
2.8
7.1
45
168
N03AE01
ATC
clonazepam; systemic
2.7
7.1
46
176
TKC20
NOMESCO Finland
Catheterisation of bladder
2.5
7.1
55
232
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
4.1
6.9
25
62
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
4.0
6.9
26
67
Y07
ICD-10 Finland
Other maltreatment
7.6
6.9
15
20
K29.2
ICD-10 Finland
Alcoholic gastritis
13.9
6.9
11
8
30088
ICD-8 Finland
Neuroses, Other
13.9
6.9
11
8
N05AA01
ATC
chlorpromazine; systemic, rectal
5.1
6.8
20
40
N05AN01
ATC
lithium; oral
3.8
6.8
27
73
R51.80
ICD-10 Finland
Headache
1.9
6.8
101
567
EBA00
NOMESCO Finland
Extraction of tooth
1.6
6.8
228
1632
Z72.2
ICD-10 Finland
Drug use
16.9
6.8
10
6
97920
ICD-8 Finland
Alcohol in combination with specified medicinal agents, With nonbarbiturate sedatives
22.7
6.7
9
*
Y90.8
ICD-10 Finland
Blood alcohol level of 240 mg/100 ml or more
22.7
6.7
9
*
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
22.7
6.7
9
*
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.7
6.7
43
164
C03CA01
ATC
furosemide; systemic
1.7
6.7
162
1065
SPAT1307
SPAT
Psychosocial counselling and guidance
2.7
6.6
44
172
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
6.6
274
2055
SPAT1227
SPAT
Substance abuse rehabilitation
8.2
6.3
13
16
F10.02
ICD-10 Finland
Alcohol-related acute intoxication with other acute clinical complications
11.1
6.3
11
10
E87.2
ICD-10 Finland
Acidosis
9.4
6.3
12
13
9802A
ICD-9 Finland
Toxic effect of alcohol, Isopropyl alcohol
+∞
6.3
6
*
X65
ICD-10 Finland
Intentional self-poisoning by and exposure to alcohol
+∞
6.3
6
*
T58
ICD-10 Finland
Toxic effect of carbon monoxide
+∞
6.3
6
*
97799
ICD-8 Finland
Adverse effect of other and unspecified drugs, Drugs, unspecified
+∞
6.3
6
*
30430
ICD-8 Finland
Drug dependence, Other hypnotics and sedatives or tranquillisers
26.9
6.2
8
*
F34.1
ICD-10 Finland
Dysthymia
3.4
6.2
28
85
A98
ICPC
Health maint/preventive medicine
0.6
6.2
602
6539
M54.4
ICD-10 Finland
Lumbago with sciatica
1.8
6.2
108
642
F99
ICD-10 Finland
Mental disorder, not otherwise specified
4.3
6.2
21
50
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
6.2
116
704
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
12.6
6.1
10
8
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
8.7
6.1
12
14
S01.7
ICD-10 Finland
Multiple open wounds of head
10.1
6.0
11
11

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020191) Ethanol [Moles/volume] in Serum or Plasma
57
56
10.87
51.60
3.7
1.4
promille
2.0
1.1
2.26
45
45
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
25
21
12.25
24.82
4.4
1.9
umol/l
79.4
90.7
0.12
11
12
(3028707) Methadone [Presence] in Urine by Screen method
56
121
4.90
24.64
5.3
2.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
67
185
3.86
21.47
8.4
2.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
130
535
2.70
21.43
6.7
3.8
mmol/l
1.3
1.9
0.73
107
427
(1001926) Buprenorphine [Presence] in Urine by Screen method
72
216
3.56
20.43
4.8
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
120
502
2.63
19.05
13.1
9.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
77
254
3.24
18.81
4.4
2.0
—
—
—
0
0
(4198724)
25
33
7.78
17.90
3.7
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
78
278
3.00
16.69
4.4
2.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
143
689
2.30
16.59
9.9
9.1
mmol/l
1.0
1.1
0.12
115
541
(3028300) Cannabinoids [Presence] in Urine
78
282
2.95
16.27
4.5
2.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
27
45
6.17
15.67
1.9
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
76
281
2.88
15.21
4.5
1.9
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
30
61
5.07
14.14
25.5
15.6
nmol/l
1351.2
1437.3
0.22
30
61
(3014576) Chloride [Moles/volume] in Serum or Plasma
145
753
2.13
13.84
11.3
7.4
mmol/l
104.1
104.1
0.02
139
737
(3002173) Hemoglobin [Mass/volume] in Arterial blood
119
582
2.22
13.18
11.2
9.9
g/l
123.2
122.9
0.06
119
561
(3027944) Amphetamines [Presence] in Urine
72
280
2.72
13.10
4.7
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
261
1688
1.80
12.93
4.9
4.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
38
105
3.75
12.17
4.1
5.5
umol/l
437.1
358.3
2.06
31
92
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
314
2187
1.71
11.76
4.4
3.4
u/l
38.4
34.3
0.79
297
2083
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
68
273
2.63
11.62
7.4
3.9
mmol/l
23.3
24.2
1.03
60
252
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
13
13
10.15
11.36
1.2
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
287
1975
1.70
11.09
4.2
2.6
u/l
55.9
57.5
0.28
272
1853
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
170
1006
1.87
11.01
3.0
1.9
%
1.7
1.5
2.50
157
884
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
423
3256
1.62
10.30
7.4
6.6
umol/l
10.9
11.5
0.66
402
3092
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
269
1873
1.65
9.68
2.9
2.1
u/l
354.3
295.5
0.25
264
1779
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
72
338
2.24
8.76
13.6
12.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
80
395
2.14
8.59
6.2
6.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
224
1532
1.64
8.47
3.7
2.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
158
1003
1.71
7.88
4.3
3.8
mmol/l
0.8
0.8
4.95
149
948
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
116
679
1.83
7.63
2.1
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
117
687
1.82
7.62
2.2
1.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
221
1545
1.59
7.51
8.4
6.8
—
—
—
0
0
(3020891) Body temperature
53
234
2.35
7.45
11.2
4.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
42
172
2.52
6.95
5.6
4.2
mmol/l
3.8
3.9
1.09
36
160
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
339
2637
1.49
6.93
11.7
6.3
mmol/l
1.2
1.2
3.35
323
2420
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
100
578
1.83
6.84
4.9
2.5
u/l
82.9
123.9
0.17
85
497
(3024928) Oxygen saturation in Venous blood
34
126
2.77
6.84
3.7
2.8
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
47
206
2.36
6.73
7.0
4.3
mmol/l
1.5
1.3
0.44
47
200
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
364
2914
1.45
6.23
10.0
7.1
mmol/l
1.2
1.2
2.97
328
2473
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
597
6560
0.67
5.89
4.7
4.2
mmol/l
4.6
4.7
1.83
557
6165
(3011397) Hemoglobin [Presence] in Urine by Test strip
194
1384
1.53
5.86
4.1
3.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
443
3705
1.43
5.83
8.6
5.0
mmol/l
7.1
6.7
2.92
428
3452
(1761868) Lipid panel - Serum or Plasma
202
2699
0.67
5.81
2.8
2.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
594
6529
0.67
5.80
4.5
4.2
mmol/l
1.4
1.4
0.97
553
6103
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
87
508
1.80
5.76
3.1
2.3
ug/l
4.7
8.9
3.46
79
460
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
168
1168
1.55
5.69
5.2
3.8
ng/l
316.1
427.1
0.26
127
889
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
571
6312
0.68
5.58
4.2
3.8
mmol/l
1.5
1.4
1.82
529
5881
(3018418) pH of Serum or Plasma
233
1743
1.47
5.55
6.6
4.0
ph
7.4
7.4
0.00
35
334
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
286
2228
1.44
5.49
4.1
3.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
310
2460
1.42
5.34
8.0
8.3
inr
1.1
1.2
2.09
83
727
(3044640) Blood type and Crossmatch panel - Blood
251
1928
1.44
5.14
2.7
2.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
188
1367
1.49
5.12
5.3
3.3
kg/l
1.0
1.0
0.97
20
187
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
142
974
1.55
5.08
2.3
1.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
135
921
1.56
4.94
2.5
2.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
239
0.20
4.91
1.2
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
614
6657
0.69
4.85
5.0
4.6
mmol/l
2.7
2.8
1.41
570
6215
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
547
4840
1.39
4.67
9.2
7.7
u/l
79.5
77.5
0.41
532
4574
(3007461) Platelets [#/volume] in Blood
699
7378
0.64
4.63
30.7
19.3
e9/l
254.1
247.8
1.57
687
7205
(3000963) Hemoglobin [Mass/volume] in Blood
700
7386
0.64
4.62
30.8
19.4
g/l
136.6
138.7
3.10
695
7289
(3010813) Leukocytes [#/volume] in Blood
700
7385
0.64
4.60
30.8
19.4
e9/l
7.4
6.7
6.44
685
7198
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
198
1483
1.44
4.58
2.6
2.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
700
7383
0.64
4.55
30.6
19.3
e12/l
4.5
4.6
2.61
684
7199
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
13
34
3.87
4.55
2.8
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
171
1248
1.47
4.53
2.9
2.4
e6/l
5.5
5.2
0.10
153
1097
(3035941) MCH [Entitic mass]
700
7382
0.64
4.52
30.5
19.2
pg
30.4
30.4
0.02
695
7287
(3024731) MCV [Entitic volume]
700
7381
0.64
4.50
30.5
19.3
fl
91.0
90.8
0.47
695
7287
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
122
1729
0.65
4.48
2.5
2.7
ug/l
0.6
0.7
0.79
86
1037
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
67
391
1.78
4.48
5.3
4.4
ng/l
129.4
86.6
0.91
58
349
(36304419) Bacteria [Presence] in Urine
214
1638
1.42
4.37
3.7
2.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
238
1858
1.40
4.34
3.8
3.1
e6/l
50.9
99.6
0.62
184
1433
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
22
4.59
4.31
1.8
4.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
22
4.59
4.31
1.8
4.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
41
206
2.04
4.29
1.8
2.2
u/l
18059.6
3048.7
—
7
85
(40761535) Cells panel - Urine sediment
79
490
1.68
4.26
4.5
3.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
26
108
2.45
4.26
3.0
2.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
309
2524
1.36
4.24
6.6
5.2
g/l
34.9
36.0
2.44
288
2379
(3009508) Creatinine [Moles/volume] in Urine
249
1967
1.38
4.21
4.8
3.2
mmol/l
7.7
8.3
0.98
216
1671
(3007853) Bacteria identified in Skin by Aerobe culture
111
751
1.55
4.21
2.0
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
206
1584
1.40
4.07
6.9
3.9
%
89.6
91.0
0.34
200
1556
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
42
759
0.53
4.02
1.6
1.8
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
7
7
10.07
4.01
2.9
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
39
198
2.02
3.99
7.2
8.9
mmol/l
1.8
1.2
1.32
39
175
(3013650) Neutrophils [#/volume] in Blood by Automated count
420
3624
1.33
3.88
13.3
9.5
e9/l
4.5
4.1
3.08
374
3193
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
585
6331
0.73
3.78
4.8
4.2
mmol/l
6.2
6.0
3.64
541
5840
(3030467) Casts [#/volume] in Urine by Automated count
214
1683
1.37
3.65
3.8
3.0
e6/l
0.5
0.5
0.02
165
1261
(3018095) Leukocytes [#/volume] in Urine
263
2141
1.34
3.57
4.7
3.6
e6/l
40.0
81.0
1.21
192
1536
(3007930) Methemoglobin/Hemoglobin.total in Blood
45
251
1.84
3.53
6.2
7.4
%
0.8
0.9
0.78
45
236
(3017143) Hepatitis C virus Ab [Presence] in Serum
112
791
1.48
3.48
1.9
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
34
174
2.00
3.43
3.6
3.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
45
254
1.82
3.40
6.3
7.3
%
2.4
1.6
2.05
45
238
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
241
2920
0.75
3.37
3.7
4.2
ug/l
2.1
2.1
0.02
216
2655
(1616796) Gas panel - Central venous blood
29
141
2.10
3.35
3.3
3.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
187
2347
0.74
3.32
3.7
3.7
%
19.4
21.1
0.88
77
1000
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
102
2.29
3.31
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
102
2.29
3.31
1.5
1.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
6
7
8.62
3.26
3.5
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
285
2373
1.31
3.25
2.4
2.2
nmol/l
71.4
74.6
1.11
266
2136
(3044242) Glucose [Moles/volume] in Arterial blood
11
33
3.37
3.20
2.3
3.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
30
152
2.01
3.13
1.6
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
154
1176
1.38
3.12
3.2
2.7
mosm/kgh2o
515.0
569.6
2.05
129
1009
(3039000) Anion gap in Blood
29
146
2.02
3.08
8.4
10.4
mmol/l
12.9
11.4
0.75
29
133
(3018572) Chloride [Moles/volume] in Blood
29
146
2.02
3.08
8.4
10.4
mmol/l
103.9
105.5
0.80
29
133
(3029937) Albumin [Presence] in Urine by Test strip
206
1655
1.33
3.00
4.4
3.4
estimate
0.0
0.0
1.08
55
581
(3009261) Glucose [Presence] in Urine by Test strip
361
3125
1.28
2.99
3.9
3.3
estimate
0.0
0.0
0.50
52
561
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
156
1203
1.37
2.97
1.6
1.7
pmol/l
430.1
37341570.4
1.43
134
1023
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
134
1016
1.38
2.83
1.9
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
355
3083
1.27
2.81
4.0
3.2
estimate
0.0
0.0
0.00
56
587
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
124
2.05
2.78
1.4
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
355
3089
1.26
2.75
5.1
4.4
estimate
0.0
0.0
0.50
60
604
(46235355) HIV 1 and 2 tests - Meaningful Use set
159
1248
1.34
2.70
2.2
1.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
24
3.78
2.67
4.2
2.9
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
112
833
1.40
2.66
3.3
2.5
g/l
2.3
2.3
0.36
102
778
(3027945) Reticulocytes/100 erythrocytes in Blood
91
654
1.44
2.61
1.8
2.6
%
1.9
1.8
0.24
82
596
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
88
629
1.45
2.60
4.1
3.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
35
200
1.78
2.60
1.7
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
105
777
1.40
2.57
3.4
2.6
%
21.3
24.3
1.44
93
680
(3021960) Folate [Moles/volume] in Serum or Plasma
166
1323
1.32
2.53
1.6
1.5
nmol/l
18.5
20.2
0.92
147
1140
(3022217) INR in Platelet poor plasma by Coagulation assay
100
736
1.41
2.52
12.4
21.2
inr
1.1
1.3
1.66
17
97
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
95
2.13
2.50
1.4
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
188
1.79
2.48
3.9
2.9
u/ml
0.3
0.3
0.16
21
102
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
57
378
1.55
2.43
1.7
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
31
175
1.80
2.41
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
31
175
1.80
2.41
1.2
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
9
27
3.36
2.39
3.9
5.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
132
1026
1.34
2.39
3.5
2.7
e6/l
1.0
1.0
0.09
82
589
(3031040) Bacteria [#/volume] in Urine by Automated count
439
3958
1.24
2.35
5.5
3.9
e6/l
181.1
2004.9
—
9
62
(42529406) Shigella sp [Presence] in Stool by Culture
31
177
1.78
2.33
1.2
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
126
1.93
2.33
1.3
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
369
3270
1.23
2.31
6.9
6.1
e9/l
2.2
2.0
0.33
337
2908
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
18
85
2.14
2.30
4.4
6.5
mg/l
11.1
10.5
0.24
13
78
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
61
417
1.50
2.27
2.0
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
271
2328
1.25
2.25
2.1
1.9
pmol/l
90.2
95.3
1.17
146
1274
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
28
157
1.81
2.24
1.5
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
30
500
0.58
2.23
1.2
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
14
60
2.36
2.22
1.6
1.7
—
—
—
0
0
(3036489) Thrombin time
40
250
1.63
2.20
1.9
2.3
s
20.0
21.7
1.43
33
222
(3001604) Monocytes [#/volume] in Blood
358
3176
1.23
2.19
7.0
6.0
e9/l
0.6
0.6
2.18
319
2770
(3006315) Basophils [#/volume] in Blood
359
3189
1.22
2.16
7.0
6.0
e9/l
0.0
0.0
0.66
319
2783
(3013115) Eosinophils [#/volume] in Blood
369
3291
1.22
2.12
8.4
6.4
e9/l
0.2
0.2
0.01
331
2927
(3019309) Folate [Moles/volume] in Red Blood Cells
127
1000
1.32
2.11
1.7
1.7
nmol/l
1207.1
1153.2
0.31
98
789
(3011648) Oxygen content in Venous blood
12
49
2.47
2.11
2.8
1.7
%
11.2
11.5
0.08
12
49
(3017817) Protein [Mass] in Urine collected for unspecified duration
12
49
2.47
2.11
3.3
2.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
56
0.00
2.07
0.0
1.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
0
58
0.00
2.04
0.0
1.8
—
40.0
—
0
7
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
21
111
1.92
2.02
1.5
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
67
479
1.43
2.02
2.1
2.8
e9/l
81.6
71.7
1.43
51
371
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
54
370
1.49
2.02
2.1
2.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
18
91
2.00
1.96
1.4
2.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
51
2.37
1.95
5.3
4.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
11
4.57
1.94
11.6
6.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
53
748
0.69
1.89
4.1
4.2
%
32.8
31.0
0.63
40
526
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
44
295
1.52
1.84
1.9
1.9
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
25
145
1.75
1.83
1.4
1.2
u/ml
366.6
280.8
0.75
20
91
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
34
215
1.61
1.82
2.4
3.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
18
94
1.94
1.81
1.2
1.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
29
2.78
1.79
2.6
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
29
177
1.66
1.78
1.9
1.8
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
31
194
1.62
1.74
1.4
1.2
titre
42.0
81.8
—
5
17
(3022948) Iron [Moles/volume] in Serum or Plasma
114
910
1.29
1.73
3.2
2.5
umol/l
12.6
13.7
0.78
107
852
(3037467) Urinalysis macro (dipstick) panel - Urine
464
4285
1.19
1.71
4.5
4.0
—
—
—
0
0
(3010421) pH of Blood
27
164
1.67
1.70
5.0
4.5
ph
7.4
7.4
0.90
20
135
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
172
1447
1.24
1.69
2.5
2.1
mg/l
2.9
3.0
0.15
146
1240
(42870588) Differential panel, method unspecified - Blood
243
2122
1.21
1.66
7.3
6.1
—
—
—
0
0
(4211845)
7
25
2.82
1.65
1.4
2.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
329
2956
1.19
1.64
4.8
4.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
76
579
1.34
1.61
2.7
2.3
g/l
0.2
0.2
1.67
70
542
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
51
363
1.43
1.61
1.7
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
120
974
1.27
1.61
3.8
2.9
e6/l
2.8
1.8
0.55
69
541
(21494755) Public health laboratory ask at order entry panel
61
815
0.73
1.60
1.3
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
218
1891
1.21
1.59
4.5
4.0
mg/mmol
18.5
9.5
0.98
147
1235
(40767503) Oxygen content in Capillary blood by calculation
22
129
1.72
1.58
3.2
2.5
%
15.7
16.6
0.31
13
68
(3023323) Follitropin [Units/volume] in Serum or Plasma
37
249
1.51
1.55
1.6
1.3
iu/l
29.4
26.5
0.13
31
211
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
120
980
1.26
1.54
3.3
3.0
mmol/l
2.4
2.4
0.02
101
870
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
570
5994
0.84
1.52
6.9
5.4
mmol/mol
41.0
39.7
1.91
533
5632
(3021879) Hepatitis B virus core Ab [Presence] in Serum
67
506
1.35
1.52
1.5
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
99
791
1.29
1.51
1.6
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
218
1900
1.20
1.51
3.7
3.4
mmol/l
2.3
2.3
0.18
198
1693
(44790049)
16
86
1.88
1.51
1.2
1.7
—
—
—
0
0
(44790048)
16
86
1.88
1.51
1.2
1.7
—
—
—
0
0
(44806118)
16
86
1.88
1.51
1.2
1.7
—
—
—
0
0
(44790047)
16
86
1.88
1.51
1.2
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
589
6174
0.84
1.50
18.4
11.9
ml/min/173m2
87.9
84.8
2.88
500
5091
(3026389) Candida sp identified in Specimen by Organism specific culture
12
58
2.08
1.49
1.2
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
94
750
1.29
1.46
4.1
2.8
umol/l
14.5
8.0
0.64
83
668
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
273
2436
1.18
1.44
4.1
3.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
34
229
1.51
1.43
1.1
1.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
6
22
2.74
1.43
6.0
6.5
mmol/l
26.9
27.0
—
6
22
(3022145) Colonoscopy Study observation
54
720
0.73
1.42
1.6
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
18
103
1.76
1.41
1.4
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
60
452
1.35
1.39
2.9
3.1
ng/l
175.3
185.7
0.09
52
408
(3009542) Hematocrit [Volume Fraction] of Blood
587
6137
0.85
1.35
23.4
14.0
%
40.4
40.9
0.68
415
4680
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
53
394
1.37
1.34
6.2
3.4
mmol/l
2.0
1.6
0.39
37
298
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
678
6994
0.82
1.31
13.0
10.0
u/l
31.5
29.3
1.36
664
6797
(3024471) HLA-A [Type]
6
24
2.51
1.30
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
24
2.51
1.30
1.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
24
153
1.59
1.30
1.5
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
21
131
1.62
1.24
1.7
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
263
2367
1.16
1.23
4.5
3.4
ng/l
44.6
42.6
0.06
184
1600
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
19
2.64
1.21
1.4
1.9
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
21
132
1.61
1.21
2.4
2.2
g/l
128.9
131.9
0.19
16
105
(3009343) pH of Capillary blood
54
411
1.34
1.20
6.3
3.3
ph
7.4
7.4
—
8
53
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
186
1631
1.18
1.20
3.1
3.1
ng/l
1254.4
1225.2
0.04
154
1384
(3018010) Neutrophils/100 leukocytes in Blood
331
3036
1.15
1.19
7.1
6.1
%
57.4
57.0
0.28
318
2865
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
26
2.32
1.19
1.5
1.7
ug/l
280.8
54.2
—
6
26
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
8
38
2.12
1.18
1.6
2.2
—
350.2
—
0
6
(3000570) Elastase.pancreatic [Mass/mass] in Stool
28
190
1.49
1.17
1.4
1.4
ug/g
217.9
290.7
0.80
14
112
(1617658) Protocol used for examination of sentinel lymph nodes
0
34
0.00
1.16
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
35
0.00
1.15
0.0
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
335
3084
1.15
1.13
7.3
6.3
%
27.9
28.1
0.07
321
2896
(3051651) Icteric interference index of Serum or Plasma
8
40
2.01
1.12
6.5
4.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
16
256
0.62
1.11
1.3
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
21
2.39
1.09
1.4
3.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
41
305
1.36
1.07
1.1
1.1
—
31.6
—
0
7
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
488
4620
1.14
1.06
5.1
3.2
u/l
67.5
52.0
1.73
468
4372
(3012501) Base excess in Blood by calculation
21
137
1.55
1.06
5.0
4.8
mmol/l
3.1
2.5
0.39
12
98
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
19
121
1.58
1.06
3.1
1.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
325
2998
1.14
1.05
7.4
6.6
%
8.6
8.7
0.35
310
2828
(40761511) CBC panel - Blood by Automated count
670
6892
0.85
1.05
19.5
12.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
15
90
1.68
1.04
5.8
1.3
mmol/l
65.7
65.2
—
9
81
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
9
46
1.97
1.03
2.8
1.4
nmol/l
18.3
19.3
—
9
41
(3045788) Cell count panel - Pleural fluid
9
46
1.97
1.03
1.7
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
161
1415
1.17
1.02
1.7
1.9
mg/l
1.1
1.1
0.01
124
1074
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
25
172
1.47
1.01
1.5
1.8
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
23
2.18
0.98
2.6
2.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
30
0.00
0.97
0.0
2.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
30
0.00
0.97
0.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
30
0.00
0.97
0.0
1.2
—
8.7
—
0
30
(3036071) Salmonella sp Ab [Titer] in Serum
0
30
0.00
0.97
0.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
193
1727
1.15
0.97
2.6
2.7
umol/l
358.1
5178.4
4.93
169
1533
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
31
0.00
0.96
0.0
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
490
4658
1.13
0.96
3.9
3.6
pmol/l
14.7
14.6
0.05
455
4257
(4034850)
31
225
1.39
0.96
10.4
9.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
6
119
0.50
0.94
2.7
4.5
u/ml
136.8
333.3
—
6
114
(3044941) Cell count panel - Synovial fluid
15
93
1.62
0.94
1.2
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
200
1798
1.15
0.94
3.8
3.3
mg/l
87.0
242.8
1.16
138
1193
(4094501)
12
196
0.61
0.93
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
55
1.83
0.92
1.0
1.0
titre
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
215
2366
0.88
0.92
2.2
2.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
17
255
0.66
0.91
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
17
110
1.56
0.91
1.0
1.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
312
2895
1.13
0.90
7.3
6.3
%
0.7
0.7
0.32
298
2721
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
85
1004
0.83
0.89
1.2
1.3
u/ml
7.7
13.9
0.52
30
427
(3023511) Choriogonadotropin [Units/volume] in Urine
18
119
1.52
0.88
1.6
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
87
736
1.20
0.86
10.6
6.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
137
1.47
0.84
1.5
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
472
4498
1.12
0.83
3.6
3.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
63
761
0.81
0.83
1.8
1.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
320
2989
1.12
0.81
7.3
6.2
%
2.8
2.9
0.24
304
2800
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
55
670
0.81
0.79
1.3
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
72
604
1.21
0.79
1.7
1.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
25
0.00
0.79
0.0
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
11
66
1.68
0.79
1.5
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
11
66
1.68
0.79
1.5
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
11
66
1.68
0.79
1.5
1.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
36
278
1.31
0.78
1.1
1.5
—
9.6
—
0
9
(3001019) Free T4 and TSH panel - Serum or Plasma
27
359
0.74
0.77
1.5
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
34
1.77
0.76
1.3
1.5
—
—
—
0
0
(4010399)
55
451
1.24
0.75
1.2
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
94
813
1.18
0.75
1.4
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
54
1.67
0.74
1.1
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
280
2615
1.11
0.70
3.1
2.7
ug/l
114.6
139.8
1.32
259
2437
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
23
169
1.37
0.70
1.6
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
301
2827
1.10
0.67
11.8
9.3
e9/l
0.0
0.0
0.59
251
2344
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
30
232
1.30
0.67
3.4
3.6
u/ml
711.0
4927.8
0.48
25
198
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
70
1.58
0.65
5.0
3.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
29
369
0.78
0.63
1.2
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
138
1.39
0.63
1.4
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
22
290
0.75
0.62
1.7
1.8
mg/l
5.2
4.3
0.19
17
208
(3035637) Corticotropin [Mass/volume] in Plasma
11
71
1.56
0.62
1.7
1.3
—
—
—
0
0
(4035726)
42
510
0.81
0.62
1.5
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
20
147
1.37
0.62
2.1
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
29
227
1.29
0.60
1.3
1.3
u/l
10.8
7.4
0.39
24
187
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(4133840)
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
60
511
1.19
0.60
3.1
2.6
ml/min/173m2
67.4
71.5
0.39
29
198
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
8
52
1.54
0.59
1.3
1.3
%
16.3
28.3
—
8
37
(3050129) First trimester maternal screen panel - Serum or Plasma
12
174
0.69
0.59
1.3
1.5
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.4
—
131.2
—
0
16
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
23
0.00
0.58
0.0
2.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
123
1.39
0.58
1.6
1.9
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
20
149
1.35
0.58
1.7
1.6
e6/l
27226.1
13589.3
0.36
15
112
(3016650) Hepatitis A virus Ab [Presence] in Serum
18
133
1.36
0.55
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
29
231
1.26
0.54
1.4
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
38
1.58
0.54
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
38
1.58
0.54
1.2
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
61
1.48
0.54
1.9
1.6
—
—
—
0
0
(3000492) Spirometry study
61
703
0.86
0.53
1.4
1.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
25
315
0.79
0.53
1.7
1.8
nmol/l
35.6
36.7
0.09
25
304
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
10
66
1.52
0.52
1.1
1.0
mg/l
257.7
274.5
—
10
61
(3002523) Influenza virus A Ag [Presence] in Specimen
9
134
0.67
0.52
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
134
0.67
0.52
1.1
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
23
179
1.29
0.51
7.0
3.3
mg/l
1.9
1.5
1.23
23
165
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
64
1.41
0.51
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
11
75
1.47
0.51
1.2
1.5
—
—
—
0
0
(4024509)
6
41
1.47
0.50
1.8
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
107
0.65
0.49
1.4
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
36
430
0.83
0.48
2.1
2.4
—
17.0
—
0
30
(3036481) Cortisol [Moles/volume] in Serum or Plasma
66
580
1.15
0.47
2.4
2.1
nmol/l
382.4
363.6
0.27
55
538
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
89
799
1.13
0.47
2.1
2.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
95
1051
0.89
0.47
1.3
1.3
iu/ml
22.8
31.3
0.66
32
341
(3000034) Microalbumin [Mass/volume] in Urine
10
68
1.48
0.47
2.3
2.9
mg/l
8.8
16.0
—
5
52
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
25
309
0.80
0.46
1.1
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
44
375
1.18
0.46
2.7
2.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
13
94
1.39
0.46
3.2
2.5
u/ml
29.9
4.5
0.46
13
89
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
16
121
1.33
0.44
1.0
1.0
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
18
140
1.29
0.42
1.5
1.4
e6/l
1331.0
1451.8
0.03
18
112
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
18
140
1.29
0.42
1.4
1.3
e6/l
8.1
10.6
0.12
18
108
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
122
1124
1.10
0.42
1.6
1.4
—
—
—
0
0
(3019225) pH of Specimen
49
561
0.87
0.41
3.5
4.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
58
1.38
0.41
1.9
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
105
1.34
0.41
1.7
1.8
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
183
0.76
0.41
1.3
1.3
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
17
0.00
0.40
0.0
2.6
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
17
0.00
0.40
0.0
5.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
18
227
0.79
0.40
1.7
2.4
u/ml
17.1
44.9
1.47
18
214
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
80
722
1.12
0.40
2.0
1.9
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
34
1.47
0.40
2.4
3.5
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
5
34
1.47
0.40
1.0
1.0
—
0.6
—
0
8
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.0
—
32.6
—
0
19
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
115
1.31
0.39
1.3
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
80
1.38
0.38
1.1
1.3
—
—
—
0
0
(1002224) Polysomnography panel
39
336
1.17
0.38
1.1
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
11
147
0.74
0.37
1.2
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
8
114
0.70
0.37
1.0
1.1
—
10.9
—
0
9
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
37
1.35
0.37
1.2
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
202
0.79
0.37
1.1
2.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
22
267
0.82
0.36
1.6
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
28
235
1.20
0.36
2.1
2.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
77
0.65
0.36
1.2
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
20
162
1.24
0.36
1.5
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
78
0.64
0.35
2.0
3.9
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
42
1.43
0.35
2.0
1.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
42
1.43
0.35
1.3
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
9
123
0.73
0.35
3.2
3.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
82
1.35
0.34
1.3
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
22
264
0.83
0.33
6.6
3.9
mmol/l
25.2
24.9
0.22
22
252
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
87
0.69
0.33
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
31
266
1.17
0.33
1.8
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
99
0.70
0.31
13.0
3.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
15
120
1.25
0.30
2.5
1.9
—
—
—
0
0
(3013512) EKG study
164
1727
0.94
0.30
4.0
3.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
56
1.25
0.29
2.0
1.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
40
355
1.13
0.28
1.4
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
76
1.32
0.28
1.2
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
62
1.29
0.28
1.3
1.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
34
299
1.14
0.28
5.1
3.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
428
4378
0.95
0.27
3.1
3.0
—
—
—
0
0
(4062490)
8
66
1.21
0.26
1.0
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
45
405
1.12
0.26
1.4
1.2
iu/ml
119.8
142.9
0.12
19
159
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
658
6502
1.06
0.26
21.2
13.5
mg/l
27.3
23.9
1.84
561
5132
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
67
1.20
0.26
1.4
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
86
1.28
0.26
2.5
2.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
77
1.30
0.26
1.3
1.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
21
179
1.18
0.25
1.3
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
75
1.20
0.25
1.4
2.7
pg
33.7
33.6
—
9
75
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
148
0.81
0.24
1.6
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
68
734
0.92
0.24
2.4
2.3
nmol/l
13.0
13.3
0.12
62
665
(3013707) Erythrocyte sedimentation rate by Westergren method
472
4631
1.05
0.24
3.6
3.9
mm/h
11.7
10.8
0.67
437
4313
(3021788) Differential panel - Synovial fluid
13
106
1.23
0.23
1.4
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
38
342
1.12
0.23
1.3
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
93
0.75
0.22
1.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
2.2
1.9
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
124
0.80
0.21
1.3
1.2
—
1.0
—
0
9
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
42
1.19
0.21
1.2
2.5
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
10
0.00
0.21
0.0
5.9
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
11.9
—
0.4
—
0
10
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.0
—
77.6
—
0
10
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
10
0.00
0.21
0.0
1.4
—
4.8
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
32
356
0.89
0.21
1.7
2.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
43
1.16
0.21
1.0
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
173
1.16
0.21
2.8
2.4
ug/min
453.9
78.7
—
10
102
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
13
0.00
0.21
0.0
3.7
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
13
0.00
0.21
0.0
1.0
—
6.6
—
0
13
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
13
0.00
0.21
0.0
1.1
—
19.8
—
0
8
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
14
0.00
0.20
0.0
2.5
—
8.7
—
0
7
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
14
0.00
0.20
0.0
3.9
—
5691.0
—
0
14
(3048879) Bone marrow aspiration report
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
13
108
1.21
0.20
1.7
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
13
108
1.21
0.20
1.6
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
133
0.82
0.19
1.0
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
51
1.18
0.19
1.0
2.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
569
5757
0.96
0.18
4.8
4.2
mu/l
1.8
2.1
0.63
527
5303
(3037522) Nuclear Ab [Titer] in Serum
90
854
1.06
0.18
1.3
1.3
titre
474.3
475.3
0.00
14
177
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
132
0.83
0.18
1.4
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
58
1.21
0.18
2.1
2.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
61
1.15
0.17
1.1
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
61
1.15
0.17
1.0
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
119
1241
0.95
0.17
1.5
1.4
g/l
2.9
2.5
0.83
70
821
(36660697) Celiac disease serology panel - Serum
51
475
1.08
0.17
1.2
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
171
1767
0.96
0.17
3.3
3.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
110
1.18
0.17
2.5
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
63
1.11
0.17
1.0
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
48
515
0.93
0.16
2.0
2.5
g/l
11.4
10.5
0.41
43
475
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
68
1.18
0.16
1.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
111
1.17
0.16
1.6
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
153
1480
1.04
0.15
4.8
4.6
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
76
0.79
0.15
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
182
0.88
0.15
1.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
79
1.14
0.15
2.6
2.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
79
1.14
0.15
1.4
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
56
527
1.07
0.15
4.5
4.7
%
1.1
0.8
0.59
24
172
(3045424) Erythrocytes [Presence] in Urine
14
121
1.16
0.15
1.3
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
671
6662
1.04
0.15
24.5
15.0
mmol/l
139.3
139.7
3.01
661
6493
(4306422)
10
118
0.85
0.14
1.1
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
80
764
1.05
0.14
1.4
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
30
276
1.09
0.13
2.9
3.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
13
149
0.87
0.13
1.7
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
100
0.80
0.13
1.9
1.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
201
0.89
0.13
1.4
2.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
46
489
0.94
0.13
5.1
4.8
%
0.3
0.2
0.51
18
155
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
117
0.85
0.13
1.2
1.6
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
18
161
1.12
0.13
1.4
1.3
mg/l
459.2
503.4
0.23
18
151
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
140
1359
1.04
0.12
1.4
1.2
u/ml
1.5
1.7
0.10
36
400
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
85
1.18
0.12
1.2
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
85
1.18
0.12
1.4
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
133
1.13
0.12
4.3
3.7
%
60.7
56.5
0.80
15
133
(40768800) Prostate Pathology biopsy report
15
168
0.89
0.11
1.1
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
16
143
1.12
0.11
1.4
1.2
mmol/l
3.8
3.8
0.08
16
134
(3035320) C reactive protein [Mass/volume] in Body fluid
5
44
1.14
0.10
3.4
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
47
1.06
0.09
2.2
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
47
1.06
0.09
1.2
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
44
462
0.95
0.09
5.2
4.9
%
0.0
0.1
1.03
16
135
(3003888) Timothy IgE Ab [Units/volume] in Serum
12
107
1.12
0.08
1.0
1.1
u/ml
8.5
8.3
—
6
52
(4146454)
7
67
1.05
0.08
3.3
2.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
68
1.03
0.08
1.1
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
70
0.86
0.07
1.2
3.1
nmol/l
6.9
79.4
—
6
70
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
73
0.82
0.07
1.2
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
76
1.05
0.07
2.0
2.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
87
1.03
0.07
2.6
3.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
89
1.13
0.07
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
101
0.89
0.06
1.1
1.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
671
6687
1.02
0.06
24.5
15.1
mmol/l
4.0
4.0
0.20
659
6514
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
129
1.09
0.05
3.6
3.2
e9/l
5.3
4.2
0.54
14
129
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
56
576
0.97
0.05
4.0
4.7
ug/l
4.7
33.1
1.25
47
479
(3003694) ABO and Rh group [Type] in Blood
186
1882
0.98
0.05
1.4
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
29
278
1.04
0.04
2.0
2.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
13
121
1.08
0.03
1.0
1.1
u/ml
2.9
2.3
—
6
50
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
210
0.95
0.03
1.7
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
149
0.94
0.03
1.4
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
171
1725
0.99
0.03
1.7
1.7
mmol/l
1.6
1.5
1.46
147
1485
(3037756) Immunofixation for Serum or Plasma
10
108
0.93
0.03
1.1
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
552
5535
0.99
0.02
26.3
16.1
%
13.8
13.6
1.96
546
5425
(3002179) Metamyelocytes/100 leukocytes in Blood
49
480
1.02
0.02
3.7
4.5
%
1.1
0.5
1.04
17
127
(3017732) Neutrophils [#/volume] in Blood
46
451
1.02
0.02
4.0
3.2
e9/l
4.2
4.2
0.05
38
365
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
23
238
0.97
0.02
2.2
1.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
26
252
1.03
0.02
1.9
2.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
10
107
0.93
0.02
2.1
2.0
%
13.7
13.2
—
10
107
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
14
133
1.05
0.01
1.6
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
15
143
1.05
0.01
1.7
2.0
iu/l
2.6
5.2
—
5
48
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
75
756
0.99
0.00
1.6
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
12
115
1.04
0.00
1.2
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
22
215
1.02
0.00
1.3
1.6
iu/ml
2.0
0.1
—
5
36
(3003327) Ova and parasites identified in Stool by Light microscopy
19
186
1.02
0.00
1.4
1.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
12
123
0.98
0.00
1.1
1.2
—
48.3
—
0
8
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
13
133
0.98
0.00
1.6
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
13
133
0.98
0.00
1.6
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
13
133
0.98
0.00
1.7
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
13
133
0.98
0.00
1.6
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
17
173
0.98
0.00
1.4
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
22
223
0.99
0.00
2.0
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
15
152
0.99
0.00
2.7
4.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
21
208
1.01
0.00
4.1
4.3
g/l
0.4
0.3
—
9
103
(40761536) Microorganisms panel - Urine sediment
53
532
1.00
0.00
3.9
3.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
77
768
1.00
0.00
2.5
2.4
ug/g
184.1
123.5
0.33
64
629
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
66
0.91
0.00
1.2
1.2
nmol/l
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(4268621)
7
79
0.89
0.00
2.1
2.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001729) Color of Synovial fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.7
—
146.3
—
0
7
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
94.5
—
0
6
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
397.4
—
0
5
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
8.7
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.1
—
0
5
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
3.9
—
—
—
0
0
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
3.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
1.5
—
0
6
(3050794) Legionella sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
10.5
—
0
5
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
76
0.92
0.00
1.1
1.3
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
5
56
0.89
0.00
1.0
1.5
—
68.6
—
0
7
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
16.5
—
0
5
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
72
0.97
0.00
1.4
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
53
0.94
0.00
2.6
1.3
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
17.9
—
0
6
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint ST19_TOXIC_EFFECT_ALCOHOL and mortality.

Females

Parameter HR [95% CI] p-value
ST19_TOXIC_EFFECT_ALCOHOL 4.993 [3.52, 7.08] < 0.001
Birth year 0.988 [0.98, 1.0] 0.009

During the follow-up period (1.1.1998 — 31.12.2019), 113 out of 999 females with ST19_TOXIC_EFFECT_ALCOHOL died.

Males

Parameter HR [95% CI] p-value
ST19_TOXIC_EFFECT_ALCOHOL 5.096 [4.25, 6.11] < 0.001
Birth year 0.986 [0.98, 1.0] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 587 out of 2166 males with ST19_TOXIC_EFFECT_ALCOHOL died.

Mortality risk

Mortality risk for people of age

years, who have ST19_TOXIC_EFFECT_ALCOHOL.

N-year risk Females Males
1 0.512% 0.933%
5 2.421% 5.27%
10 6.017% 13.689%
15 11.05% 24.353%
20 18.141% 38.048%

Relationships between endpoints

↥

Index endpoint: ST19_TOXIC_EFFECT_ALCOHOL – Toxic effect of alcohol

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data